Cypherpunk Technologies CYPH Peer Comparison

NASDAQ CYPH
$2.44 -0.19 (-7.22%)
As of: Sep 9, 2026 · 3:59 PM EDT
Peer Comparison

300 Comparable Companies

Industry Blockchain Infrastructure

Cypherpunk Technologies Inc. (CYPH) is the 191st largest of 300 Blockchain Infrastructure companies by market capitalisation, at 454.37 Mn, behind Puma Biotechnology, Inc. at 461.01 Mn. It trades on a P/E of 7.62, 58% below the peer median of 18.30. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 COIN Coinbase Global, Inc. primary T-58 Fintech TG-09 46.24 Bn -46.81 7.36 37.45 Bn
2 BLSH Bullish primary T-58 Fintech TG-09 4.41 Bn -3.16 0.02 4.30 Bn
3 CNTN Canton Strategic Holdings, Inc. primary T-58 Fintech TG-09 0.48 Bn -5.85 330.55 0.48 Bn
4 CYPH Cypherpunk Technologies Inc. primary T-58 Fintech TG-09 0.45 Bn 7.62 — 0.45 Bn
5 CNCK Coincheck Group N.V. primary T-58 Fintech TG-09 0.27 Bn -24.59 0.08 0.17 Bn
6 WEWA Wewards, Inc. primary T-58 Fintech TG-09 0.21 Bn -360.66 — 0.21 Bn
7 TONX TON Strategy Co primary T-58 Fintech TG-09 0.18 Bn -1.01 8.85 0.18 Bn
8 USBC USBC, Inc. primary T-58 Fintech TG-09 0.18 Bn -1.60 — 0.17 Bn
9 UTKN Universal Token primary T-58 Fintech TG-09 0.17 Bn -624.33 -120,805.62 0.17 Bn
10 STEX Streamex Corp. primary T-58 Fintech TG-09 0.12 Bn -0.25 715.26 0.10 Bn
11 EXOD Exodus Movement, Inc. primary T-58 Fintech TG-09 0.12 Bn -1.40 1.12 -0.23 Bn
12 FRMM FORUM MARKETS Inc primary T-58 Fintech TG-09 0.08 Bn -0.15 7.45 0.08 Bn
13 BTCS BTCS Inc. primary T-58 Fintech TG-09 0.07 Bn -1.19 3.90 -0.01 Bn
14 HYPD Hyperion Defi, Inc. primary T-58 Fintech TG-09 0.05 Bn 14.73 37.14 0.04 Bn
15 STKE SOL Strategies Inc. primary T-58 Fintech TG-09 0.02 Bn -0.22 — 0.02 Bn
16 AIXC AIxCrypto Holdings, Inc. primary T-58 Fintech TG-09 0.01 Bn -0.57 — 0.01 Bn
17 CBLO C2 Blockchain, Inc. primary T-58 Fintech TG-09 0.01 Bn -0.76 811.07 0.01 Bn
18 GNLN Greenlane Holdings, Inc. primary T-58 Fintech TG-09 0.01 Bn -0.09 4.23 -0.01 Bn
19 PDC Perpetuals.com Ltd primary T-58 Fintech TG-09 0.01 Bn — — 0.00 Bn
20 LOTT Techlott Inc. primary T-58 Fintech TG-09 0.01 Bn -0.46 — 0.01 Bn
21 IONI I-ON Digital Corp. primary T-58 Fintech TG-09 0.00 Bn 2.32 7.41 0.00 Bn
22 IPST Ip Strategy Holdings, Inc. primary T-58 Fintech TG-09 0.00 Bn -0.01 0.18 0.00 Bn
23 DCX Digital Currency X Technology Inc. primary T-58 Fintech TG-09 0.00 Bn 0.00 0.92 0.00 Bn
24 BKKT-WT Bakkt, Inc. primary T-58 Fintech TG-09 0.00 Bn -0.01 0.00 -0.05 Bn
25 GROO GROOVY COMPANY, INC. primary T-58 Fintech TG-09 0.00 Bn -0.07 5.83 0.00 Bn
26 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 643.26 Bn 30.58 6.57 622.50 Bn
27 ABBV AbbVie Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 443.31 Bn 70.19 6.89 436.74 Bn
28 MRK Merck & Co., Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 364.74 Bn 115.10 5.48 357.60 Bn
29 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 211.73 Bn 24.22 5.56 197.74 Bn
30 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 180.92 Bn -62.49 5.94 177.74 Bn
31 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 132.16 Bn 30.00 10.50 124.30 Bn
32 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 82.89 Bn 19.15 5.34 74.90 Bn
33 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 61.41 Bn 35.80 11.75 56.23 Bn
34 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 53.99 Bn -17.13 24.23 48.85 Bn
35 SNY Sanofi secondary H-01 Pharmaceuticals and Biotechnology HG-01 52.33 Bn 11.23 0.98 44.95 Bn
36 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.84 Bn 61.56 2.47 39.19 Bn
37 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 34.48 Bn 44.51 7.18 31.18 Bn
38 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 31.15 Bn 37.32 3.11 29.86 Bn
39 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 30.05 Bn -20.25 2,751.33 30.05 Bn
40 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.99 Bn -31.97 24.60 26.83 Bn
41 INCY Incyte Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 25.23 Bn 15.65 4.34 20.69 Bn
42 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 23.72 Bn -13.92 7.67 10.06 Bn
43 CRCL Circle Internet Group, Inc. secondary F-22 Capital Markets FG-05 23.15 Bn 51.31 7.97 21.42 Bn
44 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 18.20 Bn 21.48 2.14 17.79 Bn
45 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.87 Bn -49.74 12.36 15.03 Bn
46 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.87 Bn 18.30 11.19 14.92 Bn
47 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.65 Bn 22.19 4.64 15.26 Bn
48 JAZZ Jazz Pharmaceuticals plc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.22 Bn 16.17 3.31 13.60 Bn
49 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.90 Bn -21.53 20.89 14.18 Bn
50 EXEL Exelixis, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 14.62 Bn 16.98 6.00 13.78 Bn
51 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.63 Bn — — 12.94 Bn
52 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.58 Bn 30.43 7.56 12.35 Bn
53 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.45 Bn 170.57 3.65 11.57 Bn
54 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 11.85 Bn -43.53 17.69 10.24 Bn
55 AAVXF Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
56 AXSM Axsome Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.89 Bn -70.84 14.02 10.57 Bn
57 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
58 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 10.11 Bn 18.88 3.21 9.51 Bn
59 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.05 Bn -26.35 — 9.29 Bn
60 RDY Dr Reddys Laboratories Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 9.91 Bn 785.46 2.70 9.74 Bn
61 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.56 Bn 86.62 33.92 9.56 Bn
62 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.24 Bn -43.52 10.57 7.18 Bn
63 GPCR Structure Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 8.96 Bn -47.63 — 8.96 Bn
64 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.59 Bn -8.13 — 8.59 Bn
65 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.47 Bn -8.54 51.11 8.12 Bn
66 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.97 Bn -14.81 — 7.97 Bn
67 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.77 Bn 17.59 9.72 7.09 Bn
68 GIFLF Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
69 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.38 Bn -41.27 — 7.38 Bn
70 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.14 Bn -17.69 — 7.14 Bn
71 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.93 Bn -32.98 28.90 6.60 Bn
72 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.36 Bn -28.39 1,021.85 6.36 Bn
73 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.31 Bn -704.68 4,533.84 6.31 Bn
74 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.25 Bn -7.27 10.12 5.82 Bn
75 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.09 Bn 75.51 7.24 5.56 Bn
76 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.87 Bn -16.20 — 5.87 Bn
77 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn -15.79 — 5.84 Bn
78 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.83 Bn -33.11 1,160.93 5.65 Bn
79 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn 29.31 19.90 4.42 Bn
80 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.74 Bn — — 4.01 Bn
81 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.62 Bn 14.70 5.57 3.39 Bn
82 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.98 Bn -22.73 — 4.98 Bn
83 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.89 Bn -17.03 — 4.89 Bn
84 GLXY Galaxy Digital Inc. secondary F-22 Capital Markets FG-05 4.86 Bn -17.45 0.08 3.30 Bn
85 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.06 Bn -7.94 1,126.80 4.06 Bn
86 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.05 Bn — — 3.64 Bn
87 TLPPF Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.89 Bn -521.64 4.64 3.59 Bn
88 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.83 Bn -7.15 — 3.83 Bn
89 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.80 Bn -13.27 366.70 3.80 Bn
90 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.79 Bn -18.13 11.66 3.49 Bn
91 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.60 Bn -29.59 — 3.60 Bn
92 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.59 Bn -7.79 30.64 2.88 Bn
93 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.57 Bn -34.90 66.37 2.56 Bn
94 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.54 Bn -16.07 15.11 2.71 Bn
95 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.37 Bn -20.49 50.98 3.37 Bn
96 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.18 Bn -6.15 — 3.18 Bn
97 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.11 Bn 109.08 6.70 2.87 Bn
98 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.02 Bn -9.83 19,122.53 3.02 Bn
99 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.99 Bn -28.68 — 2.99 Bn
100 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -10.96 593.06 2.44 Bn
101 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.95 Bn -14.67 — 2.95 Bn
102 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.93 Bn -8.57 79.61 2.48 Bn
103 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.80 Bn -14.90 6.24 2.10 Bn
104 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.64 Bn -81.36 — 2.64 Bn
105 TAK Takeda Pharmaceutical Co Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.61 Bn 4.54 0.06 -3.19 Bn
106 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.58 Bn -8.52 49.52 2.58 Bn
107 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.51 Bn -169.96 10.01 2.40 Bn
108 BEIGF BeOne Medicines Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.48 Bn 3.74 0.40 -2.62 Bn
109 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -6.10 — 2.44 Bn
110 SUPN Supernus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -28.71 3.10 2.07 Bn
111 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.41 Bn -20.29 44.17 1.73 Bn
112 HRMY Harmony Biosciences Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.41 Bn 13.50 2.51 1.60 Bn
113 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.40 Bn -5.99 33.69 2.40 Bn
114 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.33 Bn -16.97 1.18 1.53 Bn
115 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -2,975.41 — 2.29 Bn
116 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -5.95 4.28 1.94 Bn
117 NUVB Nuvation Bio Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.28 Bn -21.11 13.44 2.28 Bn
118 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn -36.49 12.04 2.16 Bn
119 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn -3.87 — 2.00 Bn
120 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.23 Bn -11.24 — 1.86 Bn
121 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.15 Bn 12.91 4.19 2.01 Bn
122 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.14 Bn 0.17 0.34 0.63 Bn
123 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.12 Bn -8.78 — 2.12 Bn
124 AUPH Aurinia Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.11 Bn 6.70 6.76 1.66 Bn
125 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -5.01 20.99 2.06 Bn
126 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -15.00 102.87 2.06 Bn
127 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.04 Bn -5.16 — 2.04 Bn
128 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.03 Bn -4.89 2,033.16 2.03 Bn
129 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -13.21 53.36 1.71 Bn
130 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -9.53 71.80 1.69 Bn
131 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.89 Bn -11.60 18.04 1.52 Bn
132 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.82 Bn -7.23 6.00 1.82 Bn
133 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.77 Bn -9.74 7.00 1.22 Bn
134 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.76 Bn -13.23 1,357.12 1.76 Bn
135 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.75 Bn -96.63 4.06 0.87 Bn
136 GLPGF Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
137 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.72 Bn -3.31 31.30 1.17 Bn
138 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -122.77 17.33 1.71 Bn
139 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -26.90 — 1.31 Bn
140 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -6.19 — 1.09 Bn
141 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -6.57 3.93 0.91 Bn
142 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -194.01 943.71 1.62 Bn
143 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -67.19 8.06 1.32 Bn
144 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -8.63 — 1.60 Bn
145 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn -10.33 523.75 1.59 Bn
146 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
147 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.54 Bn -9.11 20.12 1.26 Bn
148 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -3.17 2.04 1.17 Bn
149 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -17.48 — 1.46 Bn
150 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -13.63 72.27 1.45 Bn
151 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -9.37 50.20 0.81 Bn
152 SDGR Schrodinger, Inc. secondary T-27 Vertical Software TG-05 1.44 Bn -26.48 5.56 1.03 Bn
153 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.43 Bn -9.65 — 1.43 Bn
154 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -8.67 — 1.42 Bn
155 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.40 Bn -4.73 — 1.40 Bn
156 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.40 Bn 82.16 36.50 1.40 Bn
157 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -9.82 — 1.37 Bn
158 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -11.30 876.13 1.17 Bn
159 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -8.64 — 1.36 Bn
160 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn -6.49 — 1.33 Bn
161 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.27 Bn -1.37 — 1.27 Bn
162 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn -5.18 150.67 0.75 Bn
163 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.23 Bn -25.77 — 1.02 Bn
164 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -28.00 3.10 1.11 Bn
165 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -11.87 50.76 1.22 Bn
166 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.16 Bn -7.56 — 1.16 Bn
167 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.14 Bn -19.84 — 1.14 Bn
168 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.12 Bn -4.64 22.98 0.66 Bn
169 ABUS Arbutus Biopharma Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 6.67 5.60 0.92 Bn
170 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn -3.82 — 0.48 Bn
171 OKYO OKYO Pharma Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.99 Bn -118.02 — 0.99 Bn
172 WVE Wave Life Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -4.81 14.90 0.61 Bn
173 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -70.03 — 0.92 Bn
174 ARDX Ardelyx, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -17.06 2.11 0.67 Bn
175 GERN Geron Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -13.99 3.86 0.64 Bn
176 TBPH Theravance Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 20.84 8.45 0.49 Bn
177 RIGL Rigel Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 2.72 3.17 0.78 Bn
178 ANNX Annexon, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.87 Bn -4.26 — 0.87 Bn
179 STTK Shattuck Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.82 Bn -15.12 816.31 0.82 Bn
180 VSTM Verastem, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.80 Bn -6.91 9.10 0.66 Bn
181 AVTX Avalo Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.80 Bn -7.93 — 0.80 Bn
182 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -9.89 95.78 0.79 Bn
183 CTMX CytomX Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.77 Bn -10.21 42.29 0.44 Bn
184 PHAR Pharming Group N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.76 Bn -122.18 2.28 0.60 Bn
185 ZURA Zura Bio Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn -6.21 — 0.72 Bn
186 ZVRA Zevra Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.71 Bn 12.24 5.24 0.49 Bn
187 VBNK VersaBank secondary F-02 Banking FG-01 0.68 Bn 1.69 6.36 0.33 Bn
188 AURA Aura Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.68 Bn -6.22 — 0.61 Bn
189 IRWD Ironwood Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn 3.03 1.72 0.59 Bn
190 SLN Silence Therapeutics plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -16.42 1,038.05 0.57 Bn
191 CRMD CorMedix Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 5.07 1.70 0.38 Bn
192 ASMB Assembly Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn 502.49 8.35 0.30 Bn
193 ALT Altimmune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.62 Bn -8.43 — 0.62 Bn
194 CBIO Crescent Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -3.75 589.05 0.44 Bn
195 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -340,055.90 — 0.60 Bn
196 TECX Tectonic Therapeutic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -6.72 — 0.58 Bn
197 VALN Valneva SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.79 3.43 0.43 Bn
198 SGMT Sagimet Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -11.82 — 0.57 Bn
199 ARVN Arvinas, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn 61.21 1.80 0.00 Bn
200 CTNM Contineum Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.40 — 0.57 Bn
201 FLGT Fulgent Genetics, Inc. secondary H-17 Healthcare Providers HG-04 0.56 Bn -6.62 2.32 0.30 Bn
202 BBOT BridgeBio Oncology Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -2.72 — 0.32 Bn
203 OVID Ovid Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.53 Bn -15.37 334.91 0.41 Bn
204 OABI OmniAb, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -11.67 13.43 0.46 Bn
205 IMUX Immunic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -4.48 — 0.52 Bn
206 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -7.41 22.27 0.22 Bn
207 PRTA Prothena Corp Public Ltd Co secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn -11.04 8.89 0.20 Bn
208 KMDA Kamada Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 15.22 2.47 0.40 Bn
209 NEUP Neuphoria Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.72 — 0.45 Bn
210 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -10.27 78.36 0.23 Bn
211 RLMD Relmada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -7.55 — 0.46 Bn
212 PBYI Puma Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 15.39 1.99 0.37 Bn
213 DRUG Bright Minds Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -15.52 — 0.45 Bn
214 CCCC C4 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.44 12.85 0.20 Bn
215 OWLS Obook Holdings Inc. secondary T-54 Fintech TG-09 0.44 Bn -14.60 63.54 0.43 Bn
216 AVIR Atea Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -3.09 — 0.42 Bn
217 RZLT Rezolute, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -5.18 — 0.42 Bn
218 ARCT Arcturus Therapeutics Holdings Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -4.40 14.27 0.23 Bn
219 CMPX Compass Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -5.07 — 0.41 Bn
220 BIOA BioAge Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -4.36 39.58 0.41 Bn
221 BTQ BTQ Technologies Corp. secondary T-42 Infrastructure Software TG-06 0.40 Bn -20.08 992.31 0.40 Bn
222 LRMR Larimar Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -2.28 — 0.24 Bn
223 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.14 39.23 0.19 Bn
224 ENTA Enanta Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -6.09 5.89 0.19 Bn
225 HMDCF HUTCHMED (China) Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
226 EYPT EyePoint, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.37 Bn -1.21 134.36 0.19 Bn
227 OFIX Orthofix Medical Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.36 Bn -8.34 0.44 0.26 Bn
228 CATX Perspective Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -3.02 — 0.36 Bn
229 OCGN Ocugen, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -4.39 78.38 0.26 Bn
230 SCTH Securetech Innovations, Inc. secondary T-61 Robotics and Automation TG-10 0.36 Bn — — 0.36 Bn
231 WHWK Whitehawk Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn -4.36 — 0.35 Bn
232 FHTX Foghorn Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -5.03 9.00 0.26 Bn
233 UPB Upstream Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -2.03 102.81 0.32 Bn
234 ELDN Eledon Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.86 — 0.32 Bn
235 EPRX Eupraxia Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -6.37 — 0.32 Bn
236 CLLS Cellectis S.A. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -7.50 5.28 0.14 Bn
237 STRO Sutro Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -2.69 3.39 0.14 Bn
238 TRDA Entrada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -1.82 64.42 0.30 Bn
239 AGEN Agenus Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 3.08 2.13 0.28 Bn
240 EQ Equillium, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -15.70 — 0.28 Bn
241 BCYC Bicycle Therapeutics Plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -1.46 4.56 0.28 Bn
242 TLSI TriSalus Life Sciences, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.28 Bn -4.74 6.17 0.23 Bn
243 ACIU AC Immune SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -5.13 12.56 0.28 Bn
244 SABS SAB Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -4.04 — 0.28 Bn
245 GALT Galectin Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -9.52 — 0.27 Bn
246 MGNX Macrogenics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -16.20 1.56 0.15 Bn
247 AKBA Akebia Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -8.70 1.18 0.10 Bn
248 ANTX AN2 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -7.05 — 0.26 Bn
249 FIXX Q32 Bio Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 63.96 — 0.15 Bn
250 AVXL Anavex Life Sciences Corp. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -18.19 — 0.14 Bn
251 IVVD Invivyd, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.01 4.50 0.09 Bn
252 ALXO Alx Oncology Holdings Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.12 — 0.25 Bn
253 CAMP Camp4 Therapeutics Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -5.05 59.91 0.25 Bn
254 ALEC Alector, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -2.87 18.17 0.08 Bn
255 CYDY CytoDyn Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -7.46 — 0.25 Bn
256 TARA Protara Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.34 — 0.23 Bn
257 CELG-RI Bristol Myers Squibb Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.03 0.00 -10.83 Bn
258 SRZN Surrozen, Inc./DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.80 20.14 0.23 Bn
259 CGEN Compugen Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 6.54 3.11 0.14 Bn
260 KRRO Korro Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.77 96.15 0.11 Bn
261 KROS Keros Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.49 6.84 -0.03 Bn
262 NMRA Neumora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.36 — 0.22 Bn
263 PYXS Pyxis Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -3.34 15.92 0.19 Bn
264 GLSI Greenwich LifeSciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -9.88 — 0.22 Bn
265 PEPG PepGen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -3.02 — 0.22 Bn
266 FUFU Bitfufu Inc. secondary T-59 Fintech TG-09 0.22 Bn -1.85 0.54 0.19 Bn
267 BGIN BGIN BLOCKCHAIN Ltd secondary T-01 Semiconductors TG-01 0.22 Bn -1.25 3.39 0.19 Bn
268 PLX Protalix BioTherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 10.07 2.64 0.17 Bn
269 TNXP Tonix Pharmaceuticals Holding Corp. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.33 7.32 0.21 Bn
270 PRQR ProQR Therapeutics N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -4.28 9.83 0.07 Bn
271 ABOS Acumen Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.98 — 0.21 Bn
272 FTH Faeth Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.05 — 0.21 Bn
273 CHRS Coherus Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -1.55 4.01 0.10 Bn
274 ARMP Armata Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -3.27 — 0.18 Bn
275 ORGO Organogenesis Holdings Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.20 Bn -2.00 0.44 0.15 Bn
276 ACOG Alpha Cognition Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -7.17 14.71 0.16 Bn
277 ORMP Oramed Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 1.15 — 0.20 Bn
278 VYGR Voyager Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -2.37 5.65 0.08 Bn
279 CUE Cue Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.92 8.65 0.18 Bn
280 ADAG Adagene Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -13.14 32.66 0.19 Bn
281 ADCT ADC Therapeutics SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.28 2.50 -0.03 Bn
282 NBP NovaBridge Biosciences secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -2.47 — 0.19 Bn
283 QNCX Quince Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.43 — 0.18 Bn
284 RDHL RedHill Biopharma Ltd. secondary H-04 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -434.89 37.17 0.18 Bn
285 IPHA Innate Pharma SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -1.11 60.09 0.18 Bn
286 MOLN Molecular Partners Ag secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.51 214.11 0.18 Bn
287 XLO Xilio Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -5.57 2.72 0.04 Bn
288 OKUR OnKure Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -2.71 — -0.01 Bn
289 RANI Rani Therapeutics Holdings, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -4.82 32.48 0.16 Bn
290 MDWD MediWound Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -5.08 13.30 0.12 Bn
291 NGEN Nervgen Pharma Corp. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -116.03 — 0.16 Bn
292 DFDV DeFi Development Corp. secondary T-29 Vertical Software TG-05 0.15 Bn -0.76 3.46 0.14 Bn
293 MIST Milestone Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn — — -0.02 Bn
294 DVLT Datavault AI Inc. secondary T-36 Infrastructure Software TG-06 0.15 Bn -0.86 3.18 0.15 Bn
295 MSLE Satellos Bioscience Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -2.84 — 0.15 Bn
296 ENTX Entera Bio Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -10.09 — 0.13 Bn
297 IFRX InflaRx N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 1,788.24 -0.04 Bn
298 WSKEF Wisekey International Holding S.A. secondary T-38 Infrastructure Software TG-06 0.14 Bn -23.16 7.29 414.94 Bn
299 UNCY Unicycive Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -4.99 — 0.14 Bn
300 SPRB Spruce Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.80 — 0.14 Bn